FITLIFE BRANDS, INC.
FTLF · Medicinal Chemicals & Botanical Products · 9.4M shares · +21%/yr ↑ shares · EDGAR filings ↗
Net buyback after stock comp: $661K (gross $779K, SBC $118K)
Reference price $9.76 · est. market cap ~$92M — last insider purchase, 2026-04-10 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
C64Supplements brand owner — profitable with positive FCF and good asset returns, but thin quick liquidity.
Strengths
- Profitable, good returns — ROA 6% (80th), ROE 14%
- Positive FCF — FCF $7M (73rd)
Risks
- Thin quick liquidity — 0.5 (55th)
- Acquisition-driven, small scale — per 10-K
- Brand/channel concentration — per 10-K
Notable findings
- BankruptcyOur largest wholesale distribution partner is GNC, which filed bankruptcy in June 2020 under Chapter 11 of the U 8-K ↗
- Customer concentration~49% of revenue from one customer/distributor — Approximately 49% of our total sales during the year ended December 31, 2025 were through Amazon’s U
- Exec changeRecent 8-K item 5.02 8-K ↗
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC, CITADEL ADVISORS LLC
- Insider buyingInsider buying — 3 open-market buy(s) by 3 insider(s) (cluster of 3 insiders, last 6mo) Form 4 ↗
- Notable holderHeld by 2 notable fund(s): STATE STREET CORP, FMR LLC (as of 2026-03-31)
- Revenue declineRevenue -17.6% YoY
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Return on equity
14.5%
Return on assets
5.9%
Revenue growth (QoQ)
-17.6%
Net-income growth
-29.6%
Current ratio
1.5×
Free cash flow
$7M
EBITDA
$10M
Tangible book value
-$27M
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-10 | Lingenbrink Matthew | Buy | 3.0K | $9.76 |
| 2026-04-10 | Dawson Grant Robert | Buy | 3.0K | $9.98 |
| 2026-01-15 | Yakatan Seth | Buy | 164 | $15.36 |
| 2025-04-15 | Ordal Todd | Buy | 300 | $12.07 |
| 2025-04-14 | Lingenbrink Matthew | Buy | 3.0K | $12.17 |
| 2025-03-31 | Lingenbrink Matthew | Buy | 2.8K | $12.17 |
| 2025-03-31 | Dayton Judd | Option exercise | 144K | $2.62 |
| 2025-03-28 | Dawson Grant Robert | Grant | 2.1K | $12.68 |
| 2025-01-15 | Ordal Todd | Buy | 150 | $30.37 |
| 2024-12-30 | Dayton Judd | Option exercise | 6.2K | $0.70 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-05-22 | 2026-05-18 | 0001437749-26-018249 ↗ |
| 10-Q | 2026-05-14 | 2026-03-31 | 0001437749-26-016875 ↗ |
| 8-K | 2026-05-14 | 2026-05-14 | 0001437749-26-016983 ↗ |
| 10-K/A | 2026-04-21 | 2025-12-31 | 0001437749-26-012937 ↗ |
| 8-K | 2026-04-07 | 2026-04-01 | 0001437749-26-011607 ↗ |
| 8-K | 2026-04-01 | 2026-04-01 | 0001437749-26-010811 ↗ |
| 10-K | 2026-03-31 | 2025-12-31 | 0001437749-26-010680 ↗ |
| 8-K | 2025-12-10 | 2025-12-10 | 0001437749-25-037314 ↗ |
| 10-Q | 2025-11-13 | 2025-09-30 | 0001437749-25-034607 ↗ |
| 8-K | 2025-11-13 | 2025-11-13 | 0001437749-25-034610 ↗ |
| 8-K/A | 2025-10-20 | 2025-08-08 | 0001437749-25-031312 ↗ |
| 8-K | 2025-08-19 | 2025-08-19 | 0001437749-25-027367 ↗ |